Summary

The Multiplex Assay market is expected to register a CAGR of approx. 7% over the period of 2022-2028. There are different types of multiplex assays, but the basic principle involves labeling each analyte with a specific probe (such as a fluorescent tag or an antibody), which is then detected and quantified using specialized instruments. The probes can be designed to bind specifically to the target analytes, allowing for highly specific and sensitive detection. Multiplex assays can be used in a variety of applications, including disease diagnosis, drug discovery, and biomarker identification. They offer several advantages over traditional single-analyte assays, including faster turnaround time, reduced sample volume requirements, and increased efficiency. Overall, multiplex assays provide a powerful tool for researchers to gain deeper insights into complex biological processes and to develop more effective diagnostic and therapeutic strategies. In addition, the introduction of novel and advanced products and the growing acceptance of these assays are likely to aid market growth.
Luminex Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Becton, Dickinson and Company, Merck KGaA, Seegene Inc., Perkin Elmer Inc., Abcam PLC, Agilent Technologies Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report
“Amongst technology, the multiplex real-time PCR category accounted for the significant share in the market in 2020”
Based on the technology, the multiplex assay market is segmented into multiplex real-time PCR, flow cytometry, and others. The multiplex real-time PCR segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe. PCR technology is widely used in a variety of end-use applications. Furthermore, the widespread use of PCR technologies for COVID-19 detection has resulted in significant revenue generation by this technology.

“Amongst application, the research & development category grabbed a considerable market share during the forecast period”
Based on the application, the market is fragmented into clinical diagnostics and research & development. The research & development segment grabbed a considerable market share during the forecast period. Multiplex assays are becoming more and more used in the drug discovery process. These tests are employed in preclinical and clinical phases to assess drug response biomarkers, immunotherapy efficacy, and toxicity.

“North America to witness significant growth during the forecast period”
For a better understanding of the market adoption of Multiplex Assay, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the multiplex assay industry owing to the presence of various research programs in the region, as well as the expansion of R&D efforts for the creation of new medications and diagnostic and therapeutic approaches. The rise in government financing for the discovery of new biomarkers and the increased frequency of chronic diseases like cancer and stroke are expected to fuel the region's growth. Furthermore, the rise is probably going to be fueled by the presence of important players in the area.

Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:
Global multiplex assay market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements

ページTOPに戻る

Table of Contents

1MARKET INTRODUCTION
1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1. Research Process of the Multiplex Assay Market
2.2. Research Methodology of the Multiplex Assay Market
2.4. Respondent Profile
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 IMPACT OF COVID-19 ON THE MULTIPLEX ASSAY MARKET
6 MULTIPLEX ASSAY MARKET REVENUE, 2020-2028F
7 MARKET INSIGHTS BY PRODUCT
7.1. Reagents & Consumables
7.2. Instruments & Accessories
7.3. Software & Services
8 MARKET INSIGHTS BY TYPE
8.1. Protein-Based Multiplex Assay
8.2. Nucleic Acid-Based Multiplex Assay
8.3. Others
9 MARKET INSIGHTS BY TECHNOLOGY
9.1. Multiplex Real-Time PCR
9.2. Flow Cytometry
9.3. Others
10 MARKET INSIGHTS BY APPLICATION
10.1 Clinical Diagnostics
10.2 Research & Development
11 MARKET INSIGHTS BY END-USER
11.1. Pharmaceutical & Biotechnology Companies
11.2. Hospitals & Diagnostic laboratories
11.3. Research & Academic Institutes
11.4. Others
12 MARKET INSIGHTS BY REGION
12.1 NORTH AMERICA
12.1.1 United States
12.1.2 Canada
12.1.3 Rest of North America
12.2 EUROPE
12.2.1 Germany
12.2.2 France
12.2.3 United Kingdom
12.2.4 Spain
12.2.5 Italy
12.2.6 Rest of Europe
12.3 ASIA PACIFIC
12.3.1 China
12.3.2 Japan
12.3.3 India
12.3.4 Australia
12.3.5 Rest of Asia Pacific
12.4 REST OF THE WORLD
13 MULTIPLEX ASSAY MARKET DYNAMICS
13.1 Market Drivers
13.2 Market Challenges
13.3 Impact Analysis
14 MULTIPLEX ASSAY MARKET OPPORTUNITIES
15 MULTIPLEX ASSAY MARKET TRENDS
16 DEMAND AND SUPPLY SIDE ANALYSIS
16.1 Demand Side Analysis
16.2 Supply Side Analysis
17 VALUE CHAIN ANALYSIS
18 STRATEGIC INSIGHTS
19 COMPETITIVE SCENARIO
19.1. Competitive Landscape
19.1.1 Porter’s Five forces analysis
20 COMPANY PROFILED
20.1. Qiagen NV
20.2. New England Biolabs
20.3. Illumina, Inc.
20.4. Bio-Rad Laboratories, Inc.
20.5. BGI Genomics Co Ltd
20.6. Oxford Nanopore Technologies PLC
20.7. PerkinElmer, Inc.
20.8. Becton Dickinson and Co
20.9. Bayer AG
20.10. Agilent Technologies Inc
21 DISCLAIMER